Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients
- PMID: 25142230
- DOI: 10.1007/s13277-014-2429-4
Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients
Abstract
The synuclein gamma (SNCG) protein, a member of neuronal protein family synuclein, has been considered as a promising potential biomarker as an indicator of cancer stage and survival in patients with cancer. The present study was conducted to evaluate the prognostic value of SNCG in patients with esophageal carcinoma (EC). SNCG levels were assessed immunohistochemically in cancer tissues from 73 EC patients. Median age was 57 (range, 29-78) years old. Forty-seven percent of the patients were male. Thirty-seven percent of the patients had upper or middle localized tumor whereas 59 % had epidermoid carcinoma. More than half of the patients (61 %) had undergone operation where 57 % received adjuvant treatment including chemotherapy or chemotherapy plus radiotherapy. Median overall survival was 11.3 ± 1.8 months (95% confidence interval (CI): 7.7-14.9 months). SNCG positivity was significantly associated with the histological type of EC and inoperability (for SNCG positive vs. negative group; epidermoid 80 vs. 53 %; p = 0.05 and inoperable 59 vs.32 %; p = 0.04, respectively). Lymph node metastasis, inoperability and receiving no adjuvant treatment had significantly adverse effect on survival in the univariate analysis (p = 0.01, p < 0.001, and p = 0.001, respectively). SNCG positivity had significantly adverse effect on survival in both univariate and multivariate analysis (p = 0.02 and p = 0.01, respectively). Our results are the first to suggest that SNCG is a new independent predictor for poor prognosis in EC patients in the literature.
Similar articles
-
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.Cancer. 2017 Apr 1;123(7):1144-1155. doi: 10.1002/cncr.30477. Epub 2016 Dec 7. Cancer. 2017. PMID: 27926776 Free PMC article.
-
Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.Int J Cancer. 2007 Sep 15;121(6):1296-305. doi: 10.1002/ijc.22763. Int J Cancer. 2007. PMID: 17534899
-
Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease.J Ovarian Res. 2016 Nov 3;9(1):75. doi: 10.1186/s13048-016-0281-4. J Ovarian Res. 2016. PMID: 27809878 Free PMC article.
-
Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen.BMC Cancer. 2010 Jul 7;10:359. doi: 10.1186/1471-2407-10-359. BMC Cancer. 2010. PMID: 20604972 Free PMC article.
-
Targeting synuclein-gamma to counteract drug resistance in cancer.Expert Opin Ther Targets. 2008 Jan;12(1):59-68. doi: 10.1517/14728222.12.1.59. Expert Opin Ther Targets. 2008. PMID: 18076370 Review.
Cited by
-
Intragenic β-synuclein rearrangements in malignancy.Front Oncol. 2023 May 12;13:1167143. doi: 10.3389/fonc.2023.1167143. eCollection 2023. Front Oncol. 2023. PMID: 37251917 Free PMC article.
-
Inhibition of SNCG suppresses the proliferation of lung cancer cells induced by high glucose.Mol Med Rep. 2021 Feb;23(2):138. doi: 10.3892/mmr.2020.11777. Epub 2020 Dec 14. Mol Med Rep. 2021. PMID: 33313952 Free PMC article.
-
Silencing of Synuclein-γ inhibits human cervical cancer through the AKT signaling pathway.Cell Mol Biol Lett. 2019 Jul 10;24:49. doi: 10.1186/s11658-019-0172-y. eCollection 2019. Cell Mol Biol Lett. 2019. PMID: 31333726 Free PMC article.
-
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.Cancer. 2017 Apr 1;123(7):1144-1155. doi: 10.1002/cncr.30477. Epub 2016 Dec 7. Cancer. 2017. PMID: 27926776 Free PMC article.
-
A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer.BMC Genomics. 2017 Sep 30;18(1):758. doi: 10.1186/s12864-017-4139-y. BMC Genomics. 2017. PMID: 28962550 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous